Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Lung Adenocarcinoma (MSKCC, Science 2015)	AL4602	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q110*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP			NA	NA	NA	14	65543349	65543349	G	A	14:g.65543349G>A	ENST00000358664.4:c.328C>T	0.06		14	239		255	236	5/5					3	59	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	0.6389	Adenocarcinoma	Transversion High	148	244	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	8.4	0	1	Male	Former	34	Matched	7.83333333333	341	SD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0007879-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R33*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	14	65560500	65560500	G	A	14:g.65560500G>A	ENST00000358664.4:c.97C>T	0.36		299	527		421	10	3/5		Pathogenic	rs387906651			68		YES		0.4227						LUAD		12.07		1	Female			Matched	9.78719697615					IMPACT410																							1:Progressed																	0.42	Commercial	2	9.433962264	90	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0005981-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q110*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	14	65543349	65543349	G	A	14:g.65543349G>A	ENST00000358664.4:c.328C>T	0.16		225	1218		735	10	5/5						60		YES		0.1121						LUAD		18.9		1	Male			Matched	9.78719697615					IMPACT410																							1:Progressed																	0.11	Clinical trial	1	9.433962264	50	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0010715-T01-IM5	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	E96*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	14	65544640	65544640	C	A	14:g.65544640C>A	ENST00000358664.4:c.286G>T	0.69	0.0028	737	330	1	353	51	4/5						67		NE		0.5186						LUNE		2.77		1	Male			Matched	49.9147045784					IMPACT410																							0:Not Progressed																	0.52	Commercial	2	48.11320755		Ever	Combination
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0006294-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X99_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	Unknown	MSKCC	14	65543382	65543382	C	A	14:g.65543382C>A	ENST00000358664.4:c.296-1G>T	0.13		75	519		212	4							63		NO		0.0515						LUAD		0.73		1	Female			Matched	3.91487879046					IMPACT410																							1:Progressed																	0.05	Commercial	2	3.773584906		Ever	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007879-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R33*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	14	65560500	65560500	G	A	14:g.65560500G>A	ENST00000358664.4:c.97C>T							10	3/5		Pathogenic	rs387906651			66				0.4227						LUAD				1	Female	Former heavy		Matched	9.78719697615			NO	KRAS	IMPACT410	YES	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	827	YES	Primary		IV	NO	YES		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005981-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q110*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	14	65543349	65543349	G	A	14:g.65543349G>A	ENST00000358664.4:c.328C>T							10	5/5						58				0.1121						LUAD				1	Male	Former heavy		Matched	9.78719697615			YES	KRAS	IMPACT410	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1121	NO	Metastasis	Note: The NKX2-1 p.H37fs mutation frequency  suggests that the mutation occurs on the amplified allele	IV	NO	YES	70	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000726-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D41Tfs*24	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	NA	MSKCC	14	65560477	65560477	T	-	14:g.65560477del	ENST00000358664.4:c.120del							29	3/5		Pathogenic				73				0.1979						LUAD				1	Female	Former heavy		Matched	32.1655037173			NO	HRAS	IMPACT341	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	413	YES	Primary		IV	NO	YES	10	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009178-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E96*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	14	65544640	65544640	C	A	14:g.65544640C>A	ENST00000358664.4:c.286G>T							13	4/5						70				0.0253						LUAD				1	Male	Former heavy		Matched	12.723356069			NO	MTOR	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	678	YES	Primary	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	IA	NO	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006855-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E32Nfs*33	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid	1	SOMATIC	NA	MSKCC	14	65560503	65560503	C	-	14:g.65560503del	ENST00000358664.4:c.94del							5	3/5						58				0.0700						LUAD				1	Female	Former light		Matched	4.89359848807			YES	KRAS	IMPACT410	YES	MSKCC	0	Bone	Adenocarcinoma	Lung	YES	Tumor	978	YES	Metastasis		IV	NO	YES	50	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002001-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q91Rfs*79	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	NA	MSKCC	14	65544654	65544654	T	-	14:g.65544654del	ENST00000358664.4:c.272del							9	4/5						58				0.5540						LUAD				1	Female	Former light		Matched	9.98239770538			NO	PIK3CA	IMPACT341	NO	MSKCC	2	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	305	NO	Metastasis		IV	NO	YES	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002989-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X58_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	14	65544755	65544755	C	A	14:g.65544755C>A	ENST00000358664.4:c.172-1G>T							4							67				0.0067						LUAD				1	Male	Former light		Matched	4.43662120239			NO	KRAS	IMPACT341	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	961	NO	Primary	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	IV	NO	YES	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008678-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X58_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	14	65544756	65544756	T	A	14:g.65544756T>A	ENST00000358664.4:c.172-2A>T							8							71		YES		0.3940						LUAD				1	Female	Former light		Matched	7.82975758092			YES	MET	IMPACT410	NO	MSKCC	1	Pleural Fluid	Adenocarcinoma	Lung	YES	Tumor	1066	NO	Metastasis		IIIA	YES	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006294-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X99_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	14	65543382	65543382	C	A	14:g.65543382C>A	ENST00000358664.4:c.296-1G>T							4							62				0.0515						LUAD				1	Female	Former heavy		Matched	3.91487879046			YES	KRAS	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	586	YES	Primary		IV	NO	YES	20	AWD																													
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0007084-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	K34_R35del	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	14	65560491	65560496	TACGTT	-	14:g.65560491_65560496del	ENST00000358664.4:c.101_106del	0.27		72	198		344	9	3/5						83		NO		0.2106						LUAD		1.63		1	Male			Matched	8.80847727853					IMPACT410																							1:Progressed																	0.21	Clinical trial	1	8.490566038	25	Ever	Combination
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0004961-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V50_P51del	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	14	65560444	65560449	TGGGAC	-	14:g.65560444_65560449del	ENST00000358664.4:c.148_153del	0.18		167	751		550	5	3/5						69		NO		0.2293						LUAD		4.37		1	Female			Matched	4.89359848807					IMPACT410																							1:Progressed																	0.23	Commercial	3	4.716981132		Ever	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009710-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R33L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	14	65560499	65560499	C	A	14:g.65560499C>A	ENST00000358664.4:c.98G>T							15	3/5						71				0.0018						LUAD				1	Female	Former heavy		Matched	14.6807954642			YES	KRAS	IMPACT410	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1266	NO	Metastasis		IIIB	NO	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007084-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	K34_R35del	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid		SOMATIC	NA	MSKCC	14	65560491	65560496	TACGTT	-	14:g.65560491_65560496del	ENST00000358664.4:c.101_106del							9	3/5						82				0.2106						LUAD				1	Male	Former light		Matched	8.80847727853			NO	KRAS	IMPACT410	NO	MSKCC	3	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	263	NO	Metastasis	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p.	IIIB	NO	YES		AWD																													
